Back to LGND Stock Lookup

Ligand Pharma (LGND) –

Jul 23, 2014 09:30 AM Ligand Partner GSK Announces Record Quarterly Promacta™/Revolade™ Revenue of $92 Million
Jul 23, 2014 08:57 AM Ligand (LGND) Pressure on GSK's Promacta Data is Overreaction - Roth Capital
Jul 22, 2014 01:16 PM SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 (LGND)
Jul 22, 2014 01:15 PM Ligand Partner SAGE Therapeutics Receives Fast Track Designation for Captisol-enabled SAGE-547 to Treat Status Epilepticus
Jul 22, 2014 10:07 AM Roth Capital Comments on Ligand (LGND) Following SAGE-547 Update
Jul 18, 2014 07:54 AM Roth Capital Sees Prelim. Q2 Revenue Numbers from Ligand (LGND) as Just the Beginning of More Success to Come
Jul 17, 2014 11:53 AM Lemelson Capital Management Announces TTM and Second Quarter 2014 Performance Results for The Amvona Fund
Jul 17, 2014 08:06 AM Form 8-K LIGAND PHARMACEUTICALS For: Jul 17
Jul 17, 2014 08:03 AM Ligand Pharma (LGND) Prelim. Q2 Revs Top Views; Approves $10M Buyback
Jul 17, 2014 08:00 AM Ligand Reports Second Quarter Revenues and Announces Share Repurchase Program
Jul 14, 2014 08:30 AM Ligand Chairman Dr. John W. Kozarich Named Director of the Year Honoree by Corporate Directors Forum
Jul 7, 2014 09:00 AM Lemelson Capital Management Further Increases Short Position in Ligand Pharmaceuticals (NASDAQ: LGND), Appends its LGND Research Report
Jul 1, 2014 12:17 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Herman Melanie J
Jul 1, 2014 12:17 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: Berkman Charles S
Jul 1, 2014 12:16 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 30 Filed by: FOEHR MATTHEW W
Jun 25, 2014 03:42 PM Roth Capital Keeps LIgand Pharma (LGND) at Buy; Glaxo Initiates Promacta Phase III
Jun 25, 2014 08:37 AM Ligand Pharma (LGND) Affirms Start of Eltrombopag + Azacitidine Phase 3 in MDS
Jun 25, 2014 08:30 AM Ligand Partner GSK Announces the Start of a Phase 3 Study with Eltrombopag in Patients with Myelodysplastic Syndromes
Jun 24, 2014 09:34 AM Roth 'Encouraged' by TG Therapeutics (TGTX), Ligand (LGND) Deal; Issues Commentary
Jun 24, 2014 08:11 AM TG Therapeutics (TGTX) Enters License Agreement for IRAK4 with Ligand (LGND); Will Get Stock + Milestones
Jun 24, 2014 08:08 AM TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4
Jun 24, 2014 08:08 AM TG Therapeutics Completes Global Licensing Agreement With Ligand Pharmaceuticals for the Development of Inhibitors of IRAK4
Jun 24, 2014 06:08 AM Ligand Pharma (LGND), TG Therapeutics (TGTX) Enter Global License for IRAK-4 Inhibitor Development
Jun 24, 2014 06:04 AM Form 8-K LIGAND PHARMACEUTICALS For: Jun 23
Jun 24, 2014 03:01 AM Ligand Signs Global License Agreement with TG Therapeutics for IRAK-4 Inhibitor Program
Jun 23, 2014 04:30 PM Ligand to Participate in ROTH Capital Partners’ Healthcare Corporate Access Day in London
Jun 23, 2014 12:04 PM Streetinsider.com's Hot Lunchtime Reads 06/23: (MSFT) (LGND) (RSH) (YELP)
Jun 23, 2014 11:28 AM Roth Capital Comments on New SERM Lasofoxifene Phase 1 Data
Jun 23, 2014 08:05 AM Ligand Pharma (LGND) Reports Positive Data from Lasofoxifene Phase 1
Jun 23, 2014 08:00 AM Ligand Announces Presentation of Positive Data from a Phase 1 Study on the Effect of the SERM Lasofoxifene to Increase Testosterone Levels in Men
Jun 17, 2014 08:54 AM UPDATE: Short-Seller Article on Ligand (LGND) is Silly, Underlying Strength Remains - Roth Capital
Jun 16, 2014 02:59 PM Lemelson Capital Makes Short Case Against Ligand Pharma (LGND)
Jun 16, 2014 10:28 AM LGD-6972 Could Drive Partnership; Roth Keeps Ligand Pharma (LGND) at 'Buy'
Jun 16, 2014 08:03 AM Ligand Pharma (LGND) Issues Positive Update on LGD-6972 Phase 1 in T2D
Jun 16, 2014 08:00 AM Ligand Announces Successful First-in-Human Trial Results for Glucagon Program
Jun 13, 2014 12:03 PM Streetinsider.com's Hot Lunchtime Reads 06/13: (PCLN) (TGTX) (NQ) (CNX)
Jun 13, 2014 11:20 AM New Promacta Data Should Support Approval for cITP; Roth has Ligand (LGND) at 'Buy'
Jun 13, 2014 07:31 AM Ligand Pharmaceuticals (LGND) Reports Phase 3 PETIT2 Met Primary Endpoint (GSK)
Jun 13, 2014 07:30 AM Ligand Partner GSK Announces Results of Phase 3 PETIT2 Study of Eltrombopag (Promacta™/Revolade™) in Pediatric Patients with Chronic Immune Thrombocytopenia
Jun 10, 2014 04:30 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 09 Filed by: Herman Melanie J
Jun 6, 2014 12:07 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 04 Filed by: Sabba Stephen L
Jun 6, 2014 11:53 AM Form 4 LIGAND PHARMACEUTICALS For: Jun 04 Filed by: KNOTT DAVID M
Jun 5, 2014 04:47 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 04 Filed by: LAMATTINA JOHN L
Jun 5, 2014 04:41 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 04 Filed by: Davis Todd C
Jun 5, 2014 04:41 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 04 Filed by: Aryeh Jason
Jun 5, 2014 04:40 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 04 Filed by: KOZARICH JOHN W
Jun 5, 2014 04:40 PM Form 4 LIGAND PHARMACEUTICALS For: Jun 04 Filed by: Patel Sunil
Jun 5, 2014 04:19 PM Form 8-K LIGAND PHARMACEUTICALS For: Jun 04
May 28, 2014 06:03 PM Form 4 LIGAND PHARMACEUTICALS For: May 27 Filed by: Berkman Charles S
May 23, 2014 07:26 AM Roth 'Encouraged' by Ligand/Viking Transaction; Maintains at 'Buy' (LGND)

Back to LGND Stock Lookup